The PR on October 20th states that 230 were enrolled as of the PR into the S/C trial. This article from today states that there CYDY has enrolled 235 into the trial, that’s 5 patients over a span of 11 days. That an enrollment rate of just more than .45 patients per day, down from the .69 patients per day from late August to October 20th.

NP said in the CC that CYDY would focus heavily on enrollment but it appears that process is taking longer than expected. The U.K. sites should start to enroll at anytime so hopefully that will help, but so far we’re on track for a February 2021 report for the 293 DSMC review.